Suicide

On Twitter yesterday, Robert Stamatakis commented: "I have to ask, I don't understand. Do you work in the UK? Your descriptions of psychiatry are nothing I recognize. These descriptions of psychiatry are nothing like the practice I see on a daily basis." I am certainly a very outspoken critic of psychiatry, and in that regard Robert's question/challenge is a fair one, to which I will try to respond. My primary criticism of modern psychiatry – and indeed the criticism that underpins all the others – is that its fundamental concepts are spurious. ...

Courtesy of yobluemama2 on Twitter, I’ve come across an interesting article. It’s called Psychiatric Drugs and Suicide, by Janne Larsson, a reporter. It’s posted on PsychRights.org, a law project for psychiatric rights. The article focuses on suicides committed in Sweden in 2006-2007, and the proportions of victims who had taken psychiatric drugs in the period prior to the suicide. The study also covers data from autopsy reports. Information for the study was gathered under Sweden’s freedom of information act. Here’s a summary of the main findings. ...

Carl Elliot has an interesting post up about the possible link between the military’s increased use of psychotropic drugs and the concomitant increase in soldiers’ suicide rates. It’s titled Note to New York Times reporters: Read the New York Times. Here’s a quote: "Like many reporters before them, James Dao and Andrew Lehren, [NY Times reporters], report that suicides in the military have risen to record levels. What they don't mention is the fact that prescriptions of psychotropic drugs, many of them with black box warnings for suicide, have also risen to record levels." ...

Another interesting article: Academic Integrity in Ireland and the UK: Is there any such thing? at Leonie fennells’ Blog. It’s about financial ties between pharmaceutical companies and psychiatrists. Same old story; different location. It’s worth a look. Thanks to Becky @yobluemama2 on Twitter for drawing my attention to this.

This issue has been debated for years, but was finally considered to have been put to rest by NIMH’s 2004 Treatment for Adolescents with Depression Study (TADS). This study essentially “found” that fluoxetine (Prozac) was effective in treating depression and did not involve an increased risk of suicide. Robert Whitaker’s most recent post points out that TADS actually found that adolescents treated with fluoxetine had a markedly higher risk for suicidal activity than those who received a placebo. Robert also outlines the various statistical and methodological ploys that were used to conceal this finding and to sanitize the final report. ...